Odonate therapeutics, inc. (ODT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net loss

-30,163

-27,851

-26,627

-28,702

-28,645

-28,763

-23,926

-19,390

-16,881

-15,746

-10,372

-3,900

-2,726

Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense

2,586

2,749

2,780

2,990

2,925

1,946

2,175

1,589

1,011

986

1,888

301

9

Depreciation and amortization

62

112

89

90

90

119

171

44

16

-

-

-

-

Non-cash contributions for expenses

-

-

-

-

-

0

0

0

64

82

42

922

766

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

2

Changes in operating assets and liabilities:
Prepaid expenses and other assets

624

-377

1,060

-491

2,744

-1,559

-793

-200

-1,199

4,092

887

-17

-6

Accounts payable

-696

2,596

5,008

201

-3,023

4,949

1,156

-528

815

3,692

-101

44

7

Accrued expenses

990

-2,504

-1,975

1,706

4,289

-1,578

3,390

1,020

1,323

993

1,754

271

166

Net cash used in operating activities

-27,845

-24,521

-21,785

-23,224

-27,108

-21,767

-16,242

-16,632

-12,453

-14,075

-7,671

-2,342

-1,770

Purchases of property and equipment

19

2

61

62

41

295

323

1,285

4

-

-

-

-

Net cash used in investing activities

-19

-2

-61

-62

-41

-295

-323

-1,285

-4

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

0

0

0

9,848

137,473

73,988

-14

10,000

Proceeds from issuance of common stock under employee stock plans

521

1,200

1,795

427

159

-

-

-

-

-

-

-

-

Net cash provided by financing activities

521

1,201

19,187

118,130

159

144

107

98

9,848

137,691

73,773

-17

10,000

Net decrease in cash and restricted cash

-27,343

-23,322

-2,659

94,844

-26,990

-21,918

-16,458

-17,819

-2,609

123,601

66,070

-2,395

8,230

Supplemental disclosure of cash flow information:
Issuance costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

0

520

37

14

Property and equipment purchases included in accounts payable and accrued expenses

7

23

-6

-40

47

-189

159

64

49

53

2

12

21

Initial recognition of right-of-use lease assets

-

0

0

0

2,215

-

-

-

-

-

-

-

-